Collections: Health Policy and Services Research / Subjects: Government Regulation and Medicare Part D - Digital Collections - National Library of Medicine Search Results

Start Over Collections Health Policy and Services Research ✖ Subjects Government Regulation ✖ Subjects Medicare Part D ✖

1. Prescription opioids: Medicare needs to expand oversight efforts to reduce the risk of harm : report to Congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, October 2017
Subject(s):: Analgesics, Opioid -- therapeutic use
Drug Utilization Review
Government Regulation
Inappropriate Prescribing
Medicare Part D
Prescription Drug Misuse
Fraud -- prevention & control
Opioid-Related Disorders
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

2. Opioid use in Medicare Part D during the onset of the COVID-19 pandemic

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, February 2021
Subject(s):: Analgesics, Opioid
COVID-19
Government Regulation
Medicare Part D
United States
United States. Department of Health and Human Services

3. Opioid overdoses and the limited treatment of opioid use disorder continue to be concerns for Medicare beneficiaries

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022
Subject(s):: Government Regulation
Medicare Part D
Opiate Overdose
Opioid-Related Disorders
United States

4. Part D plans generally include drugs commonly used by dual eligibles: 2022

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, June 2022
Subject(s):: Dual MEDICAID MEDICARE Eligibility
Government Regulation
Medicare Part D
Prescription Drugs
United States

5. The risk of misuse and diversion of buprenorphine for opioid use disorder appears to be low in Medicare Part D

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, May 2023
Subject(s):: Buprenorphine
Buprenorphine, Naloxone Drug Combination
Government Regulation
Medicare Part D
Opioid-Related Disorders -- drug therapy
United States

6. Part D plans generally include drugs commonly used by dual-eligible enrollees: 2023

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, July 2023
Subject(s):: Dual MEDICAID MEDICARE Eligibility
Formularies as Topic
Government Regulation
Medicare Part D
Prescription Drugs
United States